17.3 Acute Delirium, Encephalopathy & Severe Confusion

Definition, Neurobiology & Clinical Phenomenology of Delirium

Delirium is a severe, acute neuropsychiatric syndrome characterized by concurrent disturbances of attention, awareness, and baseline cognition. It affects 15% to 50% of hospitalized older adults, up to 80% of mechanically ventilated intensive care unit (ICU) patients, and is associated with substantial increases in hospital-acquired complications, institutionalization, accelerated long-term cognitive decline, and a 2- to 4-fold increase in in-hospital mortality.

DSM-5 Diagnostic Criteria for Delirium

To establish a definitive diagnosis of delirium, the patient must fulfill all five criteria (A through E):

• Criterion A: A disturbance in attention (reduced ability to direct, focus, sustain, and shift attention) and awareness (reduced orientation to the environment).
• Criterion B: The disturbance develops over a short period of time (typically hours to a few days), represents an acute change from baseline attention and awareness, and tends to fluctuate in severity during the course of a day.
• Criterion C: An additional disturbance in cognition (memory deficit, disorientation, language impairment, visuospatial ability, or perceptual disturbance).
• Criterion D: The disturbances in Criteria A and C are not better explained by another pre-existing, established, or evolving neurocognitive disorder and do not occur in the context of a severely reduced level of arousal, such as coma.
• Criterion E: Evidence from the history, physical examination, or laboratory findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal, exposure to a toxin, or multiple etiologies.

Pathophysiological Mechanisms & Neurotransmitter Imbalance

Delirium is the clinical manifestation of acute global cerebral microvascular failure and neuronal metabolic breakdown triggered by systemic stressors. Key mechanisms include:

1. Neuroinflammation: Peripheral infection, tissue trauma, or surgical stress triggers massive release of systemic pro-inflammatory cytokines (IL-1β, IL-6, TNF-α). These cytokines compromise blood-brain barrier permeability, activate cerebral microglia, and induce neurotoxic neuroinflammation.
2. Cholinergic Deficiency & Dopaminergic Excess: The neurochemical final common pathway of delirium involves a profound central cholinergic deficit (acetylcholine is essential for attention, vigilance, and memory encoding) coupled with a relative excess of central dopamine and noradrenaline (mediating psychomotor agitation, hyperarousal, and hallucinations). Medications with anticholinergic properties directly induce delirium by blocking central muscarinic receptors.
3. Oxidative Stress & Cellular Energy Failure: Hypoxemia, ischemia, and hypoglycemia disrupt cerebral ATP generation, leading to glutamate excitotoxicity and astrocyte swelling.

Differential Diagnosis: Delirium vs Dementia vs Depression

---

Motoric Subtypes of Delirium

Delirium is classified into three distinct motoric subtypes based on psychomotor activity and arousal level:

                         MOTORIC SUBTYPES OF DELIRIUM
                         
    ┌────────────────────────────────────────────────────────────────────────┐
    │ 1. HYPOACTIVE DELIRIUM (~50% of cases) — THE "QUIET KILLER"            │
    │ • Clinical Presentation: Somnolence, lethargy, psychomotor slowing,    │
    │   decreased spontaneous speech, apathy, staring into space, withdrawal │
    │ • Diagnostic Pitfall: FREQUENTLY MISSED or misdiagnosed as depression, │
    │   fatigue, or "a pleasant, cooperative patient"                        │
    │ • Prognosis: HIGHEST IN-HOSPITAL MORTALITY; high rates of pressure     │
    │   ulcers, aspiration pneumonia, DVT, and prolonged hospitalization     │
    └────────────────────────────────────────────────────────────────────────┘
                                        │
    ┌───────────────────────────────────┴────────────────────────────────────┐
    │ 2. HYPERACTIVE DELIRIUM (~25% of cases)                                │
    │ • Clinical Presentation: Psychomotor agitation, restlessness, combative│
    │   behavior, wandering, emotional lability, hypervigilance, screaming,  │
    │   vivid visual hallucinations, pulling at IV lines and Foley catheters │
    │ • Easily recognized by nursing and clinical teams; lowest mortality    │
    └────────────────────────────────────────────────────────────────────────┘
                                        │
    ┌───────────────────────────────────┴────────────────────────────────────┐
    │ 3. MIXED DELIRIUM (~25% of cases)                                      │
    │ • Clinical Presentation: Unpredictable fluctuations between hyperactive│
    │   and hypoactive states within a single 24-hour cycle                  │
    │ • Classically presents with daytime somnolence and quiet lethargy      │
    │   alternating with nocturnal psychomotor agitation ("sundowning")      │
    └────────────────────────────────────────────────────────────────────────┘

---

Diagnostic Assessment: The Confusion Assessment Method (CAM)

The Confusion Assessment Method (CAM) is the validated clinical reference standard for diagnosing delirium at the bedside, with a sensitivity of 94% to 100% and specificity of 90% to 95%.

The CAM Diagnostic Algorithm

To confirm a clinical diagnosis of delirium, the patient must fulfill Feature 1 AND Feature 2, alongside EITHER Feature 3 OR Feature 4:

Delirium = Feature 1 + Feature 2 + (Feature 3 OR Feature 4)

1. Feature 1: Acute Onset and Fluctuating Course:
   • Is there evidence of an acute change in mental status from the patient's baseline?
   • Does the abnormal behavior fluctuate during the day (e.g., coming and going, or increasing in severity at night)?
   • Assessment: Collateral history from family members, primary caregivers, or bedside nursing staff is mandatory.
2. Feature 2: Inattention:
   • Did the patient have difficulty focusing attention (e.g., easily distracted, unable to keep track of what was being said)?
   • Bedside Testing: Digit span testing (inability to repeat 5 digits forward or 3 digits backward); spelling the word "WORLD" backwards (normal: D-L-R-O-W); reciting the months of the year backwards (December to July); or counting backwards from 20 to 1.
3. Feature 3: Disorganized Thinking:
   • Was the patient's thinking disorganized, rambling, or incoherent? Was the conversation illogical, or did they shift unpredictably between unrelated subjects?
4. Feature 4: Altered Level of Consciousness:
   • Overall, how would you rate the patient's level of consciousness?
   • Any state OTHER THAN "ALERT" fulfills this criterion: Vigilant (hyperalert, startled by minor stimuli), Lethargic (drowsy, easily aroused by verbal stimulus but drifts off), Stuporous (difficult to arouse, requires vigorous or repeated tactile/painful stimulus), or Comatose (unresponsive).

Delirium Assessment in the ICU: CAM-ICU

In intubated, mechanically ventilated patients who cannot speak, the CAM-ICU utilizes the Richmond Agitation-Sedation Scale (RASS) to assess consciousness (Feature 4: RASS other than 0), and the Attention Screening Examination (ASE): the clinician recites 10 letters ("S-A-V-E-A-H-A-A-R-T") and instructs the patient to squeeze their hand on the letter "A"; >2 errors indicates inattention (Feature 2).

---

Systematic Etiologic Investigation: DELIRIUM & I WATCH DEATH

Delirium is never a standalone primary diagnosis; it is an emergency neurobehavioral manifestation of an underlying medical illness. Delirium results from the interaction of predisposing factors (baseline vulnerability: age ≥ 65, pre-existing dementia, functional dependency, sensory impairment, malnutrition) and precipitating factors (acute noxious insults).

The "DELIRIUM" Diagnostic Framework

                     THE "DELIRIUM" ETIOLOGICAL FRAMEWORK
                     
    ┌───┬────────────────────────────────────────────────────────────────────┐
    │ D │ DRUGS & MEDICATIONS (Most Common Reversible Precipitant)           │
    │   │ • Anticholinergics (diphenhydramine, hydroxyzine, oxybutynin, TCAs)│
    │   │ • Sedative-hypnotics (benzodiazepines, zolpidem, "Z-drugs")        │
    │   │ • Opioids (especially meperidine, codeine, high-dose morphine)     │
    │   │ • Corticosteroids, fluoroquinolones, H2-blockers, polypharmacy (≥5)│
    ├───┼────────────────────────────────────────────────────────────────────┤
    │ E │ ELECTROLYTE & METABOLIC DERANGEMENTS                               │
    │   │ • Hyponatremia (<130 mEq/L) or hypernatremia (>150 mEq/L)          │
    │   │ • Hypercalcemia, hypokalemia, hypomagnesemia                       │
    │   │ • Hypoglycemia (<50 mg/dL) or severe hyperglycemia (DKA / HHS)     │
    │   │ • Uremic encephalopathy, Hepatic encephalopathy (elevated ammonia) │
    ├───┼────────────────────────────────────────────────────────────────────┤
    │ L │ LACK OF DRUGS (ACUTE WITHDRAWAL)                                   │
    │   │ • Alcohol withdrawal (Delirium Tremens - autonomic instability)    │
    │   │ • Benzodiazepine or barbiturate withdrawal                         │
    ├───┼────────────────────────────────────────────────────────────────────┤
    │ I │ INFECTION (Occult Sepsis)                                          │
    │   │ • Urinary tract infection / pyelonephritis (most common in elderly)│
    │   │ • Pneumonia, sepsis, bacteremia, cellulitis, C. difficile colitis  │
    │   │ • CNS infections: Meningitis, viral encephalitis                   │
    ├───┼────────────────────────────────────────────────────────────────────┤
    │ R │ REDUCED SENSORY INPUT / ENVIRONMENTAL STRESS                       │
    │   │ • Missing eyeglasses or hearing aids (sensory deprivation)         │
    │   │ • Sleep deprivation, ICU psychosis, frequent room transfers        │
    ├───┼────────────────────────────────────────────────────────────────────┤
    │ I │ INTRACRANIAL PATHOLOGY                                             │
    │   │ • Acute ischemic stroke, intracerebral hemorrhage                  │
    │   │ • Subdural hematoma (occult fall in anticoagulated elderly patient)│
    │   │ • Non-convulsive status epilepticus (NCSE), brain metastasis       │
    ├───┼────────────────────────────────────────────────────────────────────┤
    │ U │ URINARY RETENTION & FECAL IMPACTION                                │
    │   │ • Severe bladder distension (post-void residual >300 mL)           │
    │   │ • Severe obstipation/impaction triggering massive sympathetic surge│
    ├───┼────────────────────────────────────────────────────────────────────┤
    │ M │ MYOCARDIAL & PULMONARY HYPOXIA / HYPERCAPNIA                       │
    │   │ • Acute myocardial infarction (frequently "silent" in elderly)     │
    │   │ • Pulmonary embolism, acute decompensated heart failure            │
    │   │ • Severe hypoxemia (PaO2 <60 mm Hg) or hypercapnia (CO2 narcosis)  │
    └───┴────────────────────────────────────────────────────────────────────┘

The "I WATCH DEATH" Systematic Mnemonic

Used globally in emergency and internal medicine rotations:

• I - Infection: UTI, pneumonia, sepsis, meningitis.
• W - Withdrawal: Alcohol, benzodiazepines, barbiturates.
• A - Acute metabolic: Electrolytes, acid-base, hepatic/uremic encephalopathy.
• T - Trauma: Subdural hematoma, hip fracture, burns.
• C - CNS pathology: Stroke, hemorrhage, tumor, seizure.
• H - Hypoxia / Hypercapnia: COPD exacerbation, PE, carbon monoxide.
• D - Deficiencies: Thiamine (Wernicke), vitamin B12, folate, niacin.
• E - Endocrine: Thyroid storm, myxedema coma, adrenal crisis, DKA.
• A - Acute vascular: Shock, hypertensive emergency, dissecting aneurysm.
• T - Toxins / Drugs: Prescriptions, illicit substances, anticholinergics.
• H - Heavy metals: Lead, mercury, arsenic, environmental toxins.

Standard Diagnostic Workup Algorithm

1. Bedside Immediate: Capillary blood glucose, continuous pulse oximetry, 12-lead ECG (silent ischemia, long QTc), bladder ultrasound scan (rule out acute urinary retention).
2. STAT Serum & Urine Laboratory Testing: CBC with differential, Comprehensive Metabolic Panel (sodium, potassium, BUN, creatinine, AST, ALT, total bilirubin, albumin), serum calcium, magnesium, phosphorus, urinalysis with microscopy and culture, blood cultures × 2, venous or arterial blood gas.
3. Toxicology & Medication Review: Urine drug screen, serum alcohol level, serum acetaminophen/salicylate, serum digoxin/lithium/phenytoin levels if prescribed.
4. Neuroimaging (Non-Contrast Head CT): Indicated if: new focal neurological deficit, history of recent fall or head trauma, unexplained fever with altered mental status, active anticoagulant therapy, or failure to identify an extracranial cause.
5. Lumbar Puncture: Mandatory if fever, nuchal rigidity, meningismus, new rash, or unexplained encephalopathy in an immunocompromised host.

---

Wernicke Encephalopathy & Korsakoff Syndrome

Wernicke encephalopathy (WE) is a hyperacute, life-threatening neurological emergency caused by an absolute or relative deficiency of thiamine (vitamin B1). If untreated, mortality approaches 20%, and 85% of survivors develop irreversible Korsakoff syndrome.

Pathophysiology & Enzymatic Cofactors

Thiamine pyrophosphate (TPP) is an indispensable coenzyme for four fundamental enzymes involved in cerebral glucose and carbohydrate metabolism:

1. Pyruvate Dehydrogenase: Links glycolysis to the citric acid (Krebs) cycle;
2. Alpha-Ketoglutarate Dehydrogenase: Krebs cycle intermediate oxidation;
3. Transketolase: Rate-limiting enzyme of the pentose phosphate pathway (synthesizes NADPH and ribose-5-phosphate for myelin and glutathione maintenance);
4. Branched-Chain Alpha-Ketoacid Dehydrogenase. When thiamine is depleted, cellular ATP synthesis halts, lactic acid accumulates, intracellular glutamate surges (excitotoxicity), and blood-brain barrier breakdown occurs. Characteristic histopathology: symmetric petechial hemorrhages, astrocytosis, and neuronal necrosis localized to the mamillary bodies, periaqueductal gray matter, walls of the third and fourth ventricles, and cerebellar vermis.

Populations at High Risk

• Chronic Alcohol Use Disorder: Most common cause. Alcohol directly inhibits active intestinal thiamine transport, impairs hepatic thiamine storage, and suppresses phosphorylation of thiamine into active TPP.
• Severe Malnutrition & Hyperemesis: Prolonged starvation, anorexia nervosa, hyperemesis gravidarum, bariatric/gastric bypass surgery, bowel obstruction, prolonged intravenous fluid administration lacking multivitamin supplementation, systemic advanced cancer, and end-stage renal disease on dialysis.

The Classic Clinical Triad

                  THE WERNICKE ENCEPHALOPATHY CLINICAL TRIAD
                  
    ┌────────────────────────────────────────────────────────────────────────┐
    │ 1. ENCEPHALOPATHY / CONFUSION                                          │
    │ • Profound global confusion, severe inattention, apathy, somnolence,   │
    │   and spatial/temporal disorientation                                  │
    ├────────────────────────────────────────────────────────────────────────┤
    │ 2. OCULOMOTOR DYSFUNCTION                                              │
    │ • Bilateral HORIZONTAL NYSTAGMUS (most common early ocular sign)       │
    │ • Bilateral LATERAL RECTUS PALSY (Abducens nerve, Cranial Nerve VI)    │
    │ • Conjugate gaze palsies, sluggish pupillary light reactions, ptosis   │
    ├────────────────────────────────────────────────────────────────────────┤
    │ 3. GAIT ATAXIA                                                         │
    │ • Broad-based, unsteady, cerebellar gait ataxia; inability to walk or  │
    │   stand unassisted due to cerebellar vermis and vestibular dysfunction │
    └────────────────────────────────────────────────────────────────────────┘

Critical Diagnostic Rule: The complete clinical triad is present in only 16% to 33% of patients. Clinicians must maintain a high index of suspicion: any patient with alcohol dependence or severe malnutrition presenting with ANY ONE of these components (acute confusion, nystagmus, or ataxia) must be treated presumptively for Wernicke encephalopathy.

THE CARDINAL CLINICAL MANDATE: THIAMINE BEFORE DEXTROSE

• The Biochemical Hazard: Intravenous administration of glucose or dextrose solutions (e.g., 5% dextrose in water [D5W]) to a thiamine-depleted individual fuels glycolysis. Rapid glycolysis instantly consumes the trace remaining thiamine cofactors in pyruvate dehydrogenase, precipitating catastrophic brainstem metabolic collapse, acute mamillary body necrosis, irreversible coma, and death.
• Treatment Protocol:
  • Administer Intravenous Thiamine 500 mg TID (infused in 100 mL 0.9% normal saline over 30 minutes) BEFORE OR CONCURRENTLY WITH ANY INTRAVENOUS DEXTROSE INFUSION.
  • Continue high-dose IV thiamine 500 mg IV every 8 hours for at least 3 to 5 consecutive days, followed by 250 mg IV daily for 3 to 5 days, then transition to oral thiamine (100 mg daily indefinitely).
  • Always administer concurrent intravenous magnesium sulfate (1 to 2 grams IV); magnesium is an obligatory cofactor for thiamine pyrophosphokinase. Thiamine administration will fail if hypomagnesemia is uncorrected.

Korsakoff Amnestic Syndrome

• The chronic, irreversible sequela of untreated or undertreated Wernicke encephalopathy secondary to selective necrosis of the mamillary bodies and medial dorsal thalamic nuclei.
• Characterized by profound anterograde amnesia (inability to acquire new episodic memories) and retrograde amnesia with temporal gradient, paired with confabulation (the spontaneous unconscious fabrication of memories to compensate for memory voids, without intent to deceive) and total lack of insight (anosognosia). Intellectual function and long-term remote memories remain largely preserved.

---

Non-Pharmacologic Management: The First-Line Foundation

Non-pharmacologic multicomponent environmental interventions represent the gold-standard, first-line therapy for all patients with delirium. The landmark Hospital Elder Life Program (HELP) demonstrated that standardized non-pharmacologic protocols reduce delirium incidence by 40% and shorten hospital length of stay.

Core Non-Pharmacologic Interventions (HELP Model)

1. Cognitive Reorientation & Environmental Support:
   • Frequent verbal reorientation by staff and family (state patient's name, current location, date, reason for hospitalization).
   • Large-print whiteboards in direct visual line showing date, day of week, and name of assigned nurse.
   • Visible wall clocks and calendars; familiar personal items and family photographs at bedside.
   • Maintain daytime natural light exposure (open window blinds); dim lighting at night.
   • Consolidate nighttime vital sign checks, phlebotomy, and medication administrations to provide an uninterrupted 4-hour sleep block.
2. Sensory Adaptation:
   • Ensure the patient's clean prescription eyeglasses and functioning hearing aids (verified with working batteries) are in place immediately upon waking. Sensory deprivation dramatically triggers disorientation and visual hallucinations.
3. Early Mobilization & Functional Activity:
   • Ambulation out of bed at least three times daily; sit upright in a chair for all meals.
   • Active range-of-motion physical therapy exercises for bedbound individuals.
4. Hydration & Nutritional Support:
   • Encourage oral fluid intake hourly; monitor volume status; assist with meal feeding; ensure clean, properly seated dental prostheses.
5. Removal of Iatrogenic Tethers:
   • Promptly remove indwelling Foley urinary catheters (catheters represent a foreign body, restrict mobility, promote bacteremia, and provoke severe agitation; replace with intermittent straight catheterization or external collection devices).
   • Discontinue unneeded IV lines, telemetry cables, and pulse oximeter probes.
6. STRICT AVOIDANCE OF PHYSICAL RESTRAINTS:
   • Physical restraints (wrist ties, vest restraints) do NOT prevent falls or tube dislodgement; they exacerbate panic, provoke extreme combative agitation, prolong delirium duration, double in-hospital mortality, and risk fatal strangulation.
   • Guideline alternative: Constant 1-on-1 bedside observation ("patient safety attendant" / sitter).

---

Pharmacologic Management: Strict Indications & High-Risk Pitfalls

Core Clinical Guideline Principles

• Antipsychotics do NOT treat, prevent, or resolve delirium. High-quality randomized controlled trials (MIND, REDUCE) show that antipsychotics do not shorten delirium duration, reduce ICU length of stay, or decrease mortality.
• Strict Indications: Pharmacotherapy is reserved strictly as a last-resort rescue for patients exhibiting severe, refractory agitation, psychosis, or combative behavior that poses an immediate, serious physical danger to the patient or staff, or directly threatens life-sustaining medical equipment (e.g., extubating endotracheal tube, pulling central venous line or dialysis catheter), when aggressive non-pharmacologic de-escalation has failed.

Pharmacological Regimens for Severe Agitation

FDA Black Box Warning & Deprescribing Mandate

• Black Box Warning: All first- and second-generation antipsychotics carry an FDA black box warning for an increased risk of all-cause mortality (primarily ischemic stroke and cardiovascular death/aspiration pneumonia) when administered to elderly patients with dementia-related psychosis.
• Immediate Deprescribing: Antipsychotics must be prescribed at the lowest effective dose for the shortest possible duration, and must be tapered and discontinued immediately once severe agitation resolves (within 24 to 48 hours). Never discharge a patient home on an antipsychotic initiated solely for hospital delirium.

THE BENZODIAZEPINE CONTRAINDICATION: A Lethal Clinical Mistake

• Strict Rule: Benzodiazepines (e.g., lorazepam, diazepam, alprazolam, midazolam) are strictly contraindicated in the routine management of delirium.
• Pathophysiological Rationale: Benzodiazepines enhance GABA-mediated central inhibition, which paradoxically causes severe behavioral disinhibition, worsening confusion, daytime somnolence, increased fall risk, and doubles the duration of delirium.
• THE ONLY TWO CLINICAL EXCEPTIONS:
  1. Delirium Tremens (Alcohol Withdrawal Delirium);
  2. Sedative-Hypnotic (Benzodiazepine / Barbiturate) Withdrawal. In these specific withdrawal syndromes, intravenous benzodiazepines administered under symptom-triggered validated protocols (e.g., CIWA-Ar) are the lifesaving treatment of choice.